NEW YORK (GenomeWeb) – Utah-based bioinformatics company Tute Genomics said today it closed a second Series A1 round of venture capital funding in which it raised over $3.9 million.

A company representative told GenomeWeb that Tute will use the funds to scale up its commercialization efforts including expanding its sales and marketing, and engineering teams. It has set aside funds from the new capital to hire a vice president of sales, a vice president of marketing, and a chief scientific officer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.